When a government withdraws from its role as steward of public health knowledge, the question of who holds that trust does not disappear — it migrates. This week, major American medical associations, including the AMA and the American Academy of Pediatrics, issued their own independent guidance on flu, COVID-19, and RSV vaccines, stepping into a void created by the Trump administration's rollback of longstanding federal recommendations. Their message was grounded in the weight of evidence: millions sickened, hundreds of thousands hospitalized, tens of thousands dead in a single season — and va
US Medical Groups Issue Independent Vaccine Guidance Amid Federal Policy Shift
Clear, consistent, science-based guidance even while the federal process is in flux
Why did these medical groups feel they had to step in now? Couldn't they have done this before?
They could have, but they didn't need to. The CDC and its advisory committees have always been the trusted source. When that system started breaking down—when the federal government began pulling back recommendations based on ideology rather than evidence—the groups realized patients were going to be confused about what to do.
But let's be precise about what changed. The administration withdrew guidance on hepatitis B for newborns and COVID for people over six months. That's significant, but it's not like all vaccine recommendations disappeared. The federal government still issued flu guidance this year.
True, but the fact that they only issued flu guidance, without updating it, is itself a signal that the normal process has stalled. And a federal judge had to step in to suspend many of the administration's measures. That's not normal.
So the medical groups are essentially saying, "We'll do the job the federal government isn't doing right now."
Exactly. They published their review online so it's transparent and accessible. They're saying: here's what the evidence actually shows, and here's what we recommend.
One thing worth noting—the medical groups cite CDC data for the burden of these illnesses. So they're not rejecting federal data; they're using it to support their own recommendations. The disagreement is about policy, not about what's actually happening.
Do we know if this independent guidance will actually reach people who need it?
That's the open question. The CDC has institutional reach and trust that a coalition, however prestigious, might not match. And we don't have data yet on whether patients are following these recommendations or whether they're confused about whose guidance to trust.
The AMA president-elect said they hope this eases "confusion and chaos." But you're right—whether it actually does is something we'll only know over time.
Il Polso
- The Trump administration has quietly dismantled decades of vaccine guidance, withdrawing recommendations for hepatitis B in newborns and COVID-19 for most Americans — leaving patients and physicians without a federal compass.
- A federal judge suspended many of these rollbacks in March, ruling the government had abandoned science-based decision-making, but the uncertainty has not lifted and this year's federal flu guidance was simply recycled from the year before.
- The scale of harm these vaccines address is not abstract: in the last respiratory season alone, influenza struck up to 52 million Americans and RSV quietly killed up to 25,000 — numbers that lend urgency to any guidance gap.
- Major medical groups responded by publishing their own independent, peer-reviewed recommendations online, explicitly designed to give patients clear and consistent guidance while federal policy remains in flux.
- Whether independent medical authority can sustain vaccination rates in the absence of federal coordination — or whether this moment marks a longer fracture in how public health guidance reaches ordinary Americans — is still unresolved.
When a government withdraws from its role as steward of public health knowledge, the question of who holds that trust does not disappear — it migrates. This week, major American medical associations, including the AMA and the American Academy of Pediatrics, issued their own independent guidance on flu, COVID-19, and RSV vaccines, stepping into a void created by the Trump administration's rollback of longstanding federal recommendations. Their message was grounded in the weight of evidence: millions sickened, hundreds of thousands hospitalized, tens of thousands dead in a single season — and vaccines that continue to offer meaningful protection. The episode raises an enduring question about the nature of scientific authority and who, in moments of institutional retreat, is responsible for the public's understanding of risk.
When the federal government retreated from its traditional role as the nation's primary source of vaccine guidance, America's largest medical organizations chose to act. On Wednesday, the American Medical Association, the American Academy of Pediatrics, and allied health groups released independent recommendations covering influenza, COVID-19, and respiratory syncytial virus — three illnesses that together caused millions of hospitalizations and tens of thousands of deaths in the past year.
The backdrop is a deliberate policy shift. The Trump administration, under Health Secretary Robert F. Kennedy Jr., has rolled back recommendations that stood for decades, including guidance on hepatitis B vaccines for newborns and COVID-19 vaccines for most Americans. A federal judge suspended many of these changes in March, finding the government had abandoned science-based decision-making, but the uncertainty has continued. This year, federal flu guidance amounted to little more than a reissue of last year's advice.
The medical groups' statement was unambiguous: current evidence shows these vaccines continue to provide meaningful protection against severe illness, hospitalization, and death, with no new safety concerns. AMA president-elect Sandra Fryhofer said the coalition's goal was to ensure patients had access to clear, credible, science-based guidance even as the federal process remained unstable. Their independent review was published openly online.
The recommendations follow the evidence: annual flu shots for everyone six months and older, updated COVID-19 vaccines for healthy adults, young children, and pregnant women, and RSV vaccines for older adults, pregnant women, and infants under eight months. The groups have been consistent critics of the administration's direction, and their independent guidance is both a practical intervention and a declaration about where medical authority belongs. Whether it will be enough to hold vaccination rates steady — and whether federal guidance will eventually be restored — remains an open question.
When the federal government stepped back from its traditional role as the primary source of vaccine guidance, a coalition of America's largest medical organizations decided to fill the void themselves. On Wednesday, the American Medical Association, the American Academy of Pediatrics, and other leading health groups released their own recommendations for influenza, COVID-19, and respiratory syncytial virus—three respiratory illnesses that collectively sickened millions of Americans in the past year alone.
The move was born of necessity. The Trump administration, pursuing what it framed as a sweeping overhaul of vaccine policy, has been rolling back recommendations that had stood for decades. The administration withdrew guidance for the hepatitis B vaccine in newborns and the COVID-19 vaccine for anyone over six months old. Health Secretary Robert F. Kennedy Jr., a longtime vaccine skeptic, has overseen these changes. A federal judge suspended many of the administration's measures in March, ruling that the government had abandoned science-based decision-making, but the uncertainty has persisted. This year, the federal government issued guidance only for the flu, extending last year's advice without updating it.
Into this gap stepped the medical groups. Their statement was direct: "The latest high-quality scientific evidence found that these immunisations continue to provide meaningful protection against severe illness, hospitalisation and death." They emphasized that recent scientific studies had raised no new safety concerns. Sandra Fryhofer, the AMA's president-elect, told reporters that the coalition wanted to provide "clear, credible, and based on the best available scientific evidence" recommendations so patients could make informed decisions. She noted that the coalition had published its independent review online, ensuring the public had "clear, consistent, science-based guidance even while the federal process is in flux."
The numbers behind the recommendations are substantial. During the 2025-2026 respiratory virus season, influenza struck between 32 million and 52 million Americans, hospitalized 390,000, and killed 24,000. COVID-19 infected between 4.6 million and 12.9 million people, hospitalized 140,000 to 240,000, and caused 15,000 to 42,000 deaths. RSV, often overlooked, generated 2.8 million to 5.8 million outpatient visits, hospitalized 170,000 to 340,000 people, and killed up to 25,000. While influenza and COVID declined compared to the previous season, RSV activity remained relatively stable.
The medical groups' guidance reflects these realities. They recommend annual flu shots for everyone six months and older. For COVID-19, they advise updated vaccines for healthy adults, young children, and pregnant women. RSV vaccines are recommended for older adults, pregnant women, and infants younger than eight months. The recommendations vary by age group and individual circumstances, acknowledging that risk profiles differ across the population.
The medical associations have been vocal opponents of the administration's vaccine policy changes, repeatedly stating that the shifts contradict scientific consensus. Their independent guidance represents both a practical response to federal uncertainty and a statement about where medical authority should rest. Whether this independent effort will prove sufficient to maintain vaccination rates—or whether the federal government will eventually restore its traditional advisory role—remains to be seen.
Citazioni salienti
Patients need and deserve vaccine recommendations that are clear, credible, and based on the best available scientific evidence, so they can make informed vaccine decisions for themselves and for their families.— Sandra Fryhofer, AMA president-elect
The latest high-quality scientific evidence found that these immunisations continue to provide meaningful protection against severe illness, hospitalisation and death.— Coalition of medical groups